Asking the right questions, recruiting the right patients: AI in clinical trials

From discovering compounds that could eventually become drugs to training chatbots to support patients taking those drugs, artificial intelligence can play a role anywhere along the drug development cycle. One of those points is clinical trials, where this technology can make studies easier for patients and investigators to navigate, and ultimately help biopharma companies make the best drugs they can.

The key is selecting the right tool for the job, said panelists during a Fierce AI Week discussion. “Artificial intelligence” in biopharma has become an umbrella term encompassing true AI, machine learning, deep learning, computer vision, biostatistics and data science.